CTech 24/7
- Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development
- “We will see a lot of mid-sized mid-market companies evaporate in the coming years”
- Cyera CEO: “We allow enterprises to move quickly with AI but to do it responsibly and securely”
- AI or die: Microsoft and investors warn startups must adapt
More stories in CTechYoel Esteron
31 stories about Yoel Esteron
The bet on Israeli tech is paying off—and 2025 will prove it
High-tech must triumph over the kakistocracy
Netanyahu wanted an autocracy but ended up with a kakistocracy
Miami extends warm embrace to Israeli innovation
Florida enthusiastically welcomes Calcalist conference to Miami
"Investing in Israel, especially now, is a wise decision that will yield great rewards"
Rage is not an action plan
Come with us to the future of Israel
Wake up! US Jewry must act now
It is difficult to be optimistic, but we have no choice
Don't short Israel's stock
High-tech must be the driving engine of the new Israel
10 essential national tasks for the new year
Sometimes nightmares come true
"Trade between Israel and Japan is growing...but we can do more"
The disillusionment is long and partial. But it has started
"Israel will survive this autoimmune attack on its democracy"
Don’t give up on us, not yet
“Do not go gentle into that good night”
Will high-tech survive in the new Israel?
Load more
